PN355: Began a 90-day Phase I trial in 10 patients with HIV and 3 normal subjects

Paracelsian Inc. (PRLN), Ithaca, N.Y. Product: PN355, pure compound derived from a Chinese herb extract Indication: HIV Status: Began a 90-day Phase I trial in 10 patients with HIV and 3 normal subjec...